TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹501 Cr | ₹445 Cr | ₹393 Cr | ₹369 Cr | ₹370 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹445 Cr |
| Mar2023 | ₹393 Cr |
| Mar2022 | ₹369 Cr |
| Mar2021 | ₹370 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹501 Cr | 12.72 | |
| Mar2024 | ₹445 Cr | 13.14 | |
| Mar2023 | ₹393 Cr | 6.60 | |
| Mar2022 | ₹369 Cr | -0.24 | |
| Mar2021 | ₹370 Cr | - | |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹133,317.8 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹85,019.3 Cr | -0.4% | -10.9% | -16.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.3% |
-3.7% |
24% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses